International Journal of Endocrinology and Metabolism

Published by: Kowsar

Macrofollicular Variant of Papillary Thyroid Cancer: A Clinicopathologic and Molecular Review

Emad Raddaoui 1 , *
Author Information
1 Department of Pathology, King Khalid University Hospital, College of Medicine, King Saud University, Riyadh, Saudi Arabia
Article information
  • International Journal of Endocrinology and Metabolism: January 01, 2015, 13 (2); e16538
  • Published Online: December 16, 2014
  • Article Type: Review Article
  • Received: December 19, 2013
  • Revised: September 1, 2014
  • Accepted: November 15, 2014
  • DOI: 10.5812/ijem.16538

To Cite: Raddaoui E. Macrofollicular Variant of Papillary Thyroid Cancer: A Clinicopathologic and Molecular Review, Int J Endocrinol Metab. 2015 ; 13(2):e16538. doi: 10.5812/ijem.16538.

Copyright © 2014, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Ito Y, Hirokawa M, Uruno T, Kihara M, Higashiyama T, Takamura Y, et al. Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology. 2008; 40(6): 617-22[DOI][PubMed]
  • 2. Albores-Saavedra J, Gould E, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol. 1991; 22(12): 1195-205[PubMed]
  • 3. Lugli A, Terracciano LM, Oberholzer M, Bubendorf L, Tornillo L. Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. Arch Pathol Lab Med. 2004; 128(1): 54-8[DOI][PubMed]
  • 4. Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003; 97(5): 1181-5[DOI][PubMed]
  • 5. Gamboa-Dominguez A, Vieitez-Martinez I, Barredo-Prieto BA, Richaud-Patin Y, Herrera ME, Angeles-Angeles A. Macrofollicular Variant of Papillary Thyroid Carcinoma: A Case and Control Analysis. Endocr Pathol. 1996; 7(4): 303-8[PubMed]
  • 6. Hagag P, Hod N, Kummer E, Cohenpour M, Horne T, Weiss M. Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up. Cancer J. 2006; 12(4): 275-82[PubMed]
  • 7. Elsheikh TM, Asa SL, Chan JK, DeLellis RA, Heffess CS, LiVolsi VA, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008; 130(5): 736-44[DOI][PubMed]
  • 8. Fukushima M, Ito Y, Hirokawa M, Kobayashi K, Miya A, Takamura Y, et al. Macrofollicular variant of papillary thyroid carcinoma: its clinicopathological features and long-term prognosis. Endocr J. 2009; 56(3): 503-8[PubMed]
  • 9. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope. 1997; 107(1): 95-100[PubMed]
  • 10. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985; 55(4): 805-28[PubMed]
  • 11. Loree TR. Therapeutic implications of prognostic factors in differentiated carcinoma of the thyroid gland. Semin Surg Oncol. 1995; 11(3): 246-55[PubMed]
  • 12. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107(6): 1255-64[DOI][PubMed]
  • 13. Said Raddaoui EM, Sayage-Rabie L, Beissner RS. Fine needle aspiration cytology in the evaluation of lymphoid lesions: a retrospective study of the utility of flow cytometry in conjunction with morphology. Ann Saudi Med. 2012; 32(2): 137-42[PubMed]
  • 14. Raddaoui E. Clinical utility and diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration of pancreatic lesions: Saudi Arabian experience. Acta Cytol. 2011; 55(1): 26-9[DOI][PubMed]
  • 15. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med. 1993; 13(3): 699-709[PubMed]
  • 16. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993; 118(4): 282-9[PubMed]
  • 17. Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994; 73(2): 424-31[PubMed]
  • 18. Akerman M, Tennvall J, Biorklund A, Martensson H, Moller T. Sensitivity and specificity of fine needle aspiration cytology in the diagnosis of tumors of the thyroid gland. Acta Cytol. 1985; 29(5): 850-5[PubMed]
  • 19. Chen H, Zeiger MA, Clark DP, Westra WH, Udelsman R. Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg. 1997; 184(6): 605-10[PubMed]
  • 20. Emad R, Maha A, Kfoury HK, Al-Sheikh AM, Zaidi SN. Three cases of macrofollicular variant of papillary thyroid carcinoma. Ann Saudi Med. 2011; 31(6): 644-7[DOI][PubMed]
  • 21. Bongiovanni M, Gremaud M, Moulin CS, Scheidegger C, Biton C, Clement S. Macrofollicular variant of follicular thyroid carcinoma: a clinical, cytologic, morphologic, and image analysis study of a unique case. Ann Diagn Pathol. 2009; 13(2): 101-5[DOI][PubMed]
  • 22. Hirokawa M, Shimizu M, Terayama K, Kanahara T, Sonoo H, Manabe T. Macrofollicular variant of papillary thyroid carcinoma. Report of a case with fine needle aspiration biopsy findings. Acta Cytol. 1998; 42(6): 1441-3[PubMed]
  • 23. Chen H, Nicol TL, Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg. 1995; 222(1): 101-6[PubMed]
  • 24. Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL. Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg. 2001; 233(5): 716-22[PubMed]
  • 25. McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A. Follicular or Hurthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 1999; 126(4): 798-802[PubMed]
  • 26. Mesonero CE, Jugle JE, Wilbur DC, Nayar R. Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid. Cancer. 1998; 84(4): 235-44[PubMed]
  • 27. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002; 117(1): 143-50[DOI][PubMed]
  • 28. Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants. Endocr Pathol. 2005; 16(4): 323-30[PubMed]
  • 29. Fadda G, Fiorino MC, Mule A, LiVolsi VA. Macrofollicular encapsulated variant of papillary thyroid carcinoma as a potential pitfall in histologic and cytologic diagnosis. A report of three cases. Acta Cytol. 2002; 46(3): 555-9[PubMed]
  • 30. Renshaw AA, Gould EW. Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117(1): 19-21[DOI][PubMed]
  • 31. Chan J. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117(1): 16-8[DOI][PubMed]
  • 32. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004; 11(6): 279-87[PubMed]
  • 33. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocr Pathol. 2002; 13(1): 3-16[PubMed]
  • 34. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, 2nd, Tallini G, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003; 88(5): 2318-26[DOI][PubMed]
  • 35. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, de Micco C. Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab. 2003; 88(6): 2745-52[DOI][PubMed]
  • 36. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab. 2002; 87(8): 3947-52[DOI][PubMed]
  • 37. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science. 2000; 289(5483): 1357-60[PubMed]
  • 38. Fukahori M, Yoshida A, Hayashi H, Yoshihara M, Matsukuma S, Sakuma Y, et al. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort. Thyroid. 2012; 22(7): 683-9[DOI][PubMed]
  • 39. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol. 1998; 185(1): 71-8[DOI][PubMed]
  • 40. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003; 22(29): 4578-80[DOI][PubMed]
  • 41. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003; 63(7): 1454-7[PubMed]
  • 42. Castro P, Rebocho AP, Soares RJ, Magalhaes J, Roque L, Trovisco V, et al. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2006; 91(1): 213-20[DOI][PubMed]
  • 43. Trovisco V, Vieira de Castro I, Soares P, Maximo V, Silva P, Magalhaes J, et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol. 2004; 202(2): 247-51[DOI][PubMed]
  • 44. De Falco V, Giannini R, Tamburrino A, Ugolini C, Lupi C, Puxeddu E, et al. Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma. J Clin Endocrinol Metab. 2008; 93(11): 4398-402[DOI][PubMed]
  • 45. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid. 2009; 19(12): 1351-61[DOI][PubMed]
  • 46. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, et al. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid. 2009; 19(8): 837-42[DOI][PubMed]
  • 47. Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL. Oncogene profile of papillary thyroid carcinoma. Surgery. 1999; 125(1): 46-52
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments